CD274 and neoplasm: However, evaluating PD-L1 expression in tumor tissue is challenging, including different results of PD-L1 expression according to different anti-PD-L1 antibodies [14], heterogeneity of PD-L1 expression in tumor tissues, highly dynamic changes in advanced malignancies and inconvenience of dynamic detection, and the predicted value may be controversial [15–17].